WS #13334
First two US deaths in cyclospora outbreak in Michigan, cases top 11,000, pressuring Sweetgreen (-7%) and Yum (-2%). Investors rejected the $400B merger talks between AstraZeneca and Bristol Myers, with AZN down 8% and BMY down, signaling deal skepticism.
Cyclospora outbreak pressures restaurant stocks
First two US deaths in cyclospora outbreak in Michigan, cases top 11,000, pressuring Sweetgreen (-7%) and Yum (-2%).
Investors rejected the $400B merger talks between AstraZeneca and Bristol Myers, with AZN down 8% and BMY down, signaling deal skepticism.